Abortion News & Analysis
2 articles
Market Mood
Texas Court Dismisses Midwife Abortion Ban Lawsuit Over Evidence
A Texas court has dismissed a lawsuit claiming that a midwife violated state laws banning abortion due to insufficient evidence. The case's outcome reflects ongoing legal challenges related to abortion access in Texas. This ruling could have implications for both midwives and patients in the state's healthcare landscape. The dismissal indicates a potential barrier for future lawsuits aimed at enforcing abortion restrictions, influencing legal interpretations and healthcare practices in Texas.
Read More: Texas Court Dismisses Midwife Abortion Ban Lawsuit Over Evidence
Danco Laboratories (Danco) Seeks Supreme Court Stay on Mifepristone Ruling
Danco Laboratories filed an application with the U.S. Supreme Court on March 23, 2024, seeking to halt an appeals court ruling that blocks mail-order access to the abortion drug mifepristone. The ruling, issued by a conservative three-judge panel, significantly limits access nationwide amidst challenges related to the drug's safety. The 2023 FDA regulation allowing mail prescriptions is under scrutiny, with only 2% of prescriptions filled in-person according to USC research. This case has substantial implications for abortion access in states where it is legal, as well as potential impacts on Danco's market position, given Mifeprex is its only product.
Read More: Danco Laboratories (Danco) Seeks Supreme Court Stay on Mifepristone Ruling